Biotest GmbH KGaA (LTS:0N6Z) Inventories, Work In Process: £0.00 Mil (As of . 20)


What is Biotest GmbH KGaA Inventories, Work In Process?

Biotest GmbH KGaA LTS:0N6Z Inventories, Work In Process is £0.00 Mil as of . 20.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Biotest GmbH KGaA's work in process for the quarter that ended in . 20 was £0.00 Mil.

Biotest GmbH KGaA Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Biotest GmbH KGaA's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest GmbH KGaA Inventories, Work In Process Chart

Biotest GmbH KGaA Annual Data
Trend
Inventories, Work In Process

Biotest GmbH KGaA Semi-Annual Data
Inventories, Work In Process

Biotest GmbH KGaA Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of £0.00 Mil mean?
Biotest GmbH KGaA (LTS:0N6Z) has a Inventories, Work In Process of £0.00 Mil as of . 20. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Biotest GmbH KGaA and its competitors.
Is Biotest GmbH KGaA's Inventories, Work In Process too high?
Biotest GmbH KGaA's current Inventories, Work In Process is £0.00 Mil.
How does Biotest GmbH KGaA's Inventories, Work In Process compare to ?
Biotest GmbH KGaA's Inventories, Work In Process of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Biotest GmbH KGaA and its competitors. Biotest GmbH KGaA's current Inventories, Work In Process is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotest GmbH KGaA stock overvalued right now?
Biotest GmbH KGaA (LTS:0N6Z) has a current Inventories, Work In Process of £0.00 Mil. The current Inventories, Work In Process is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Biotest GmbH KGaA (LTS:0N6Z), the current Inventories, Work In Process is £0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotest GmbH KGaA Business Description

Comparable Companies
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.